# Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

> **NCT02874560** · — · COMPLETED · sponsor: **Janssen-Cilag Ltd.** · enrollment: 364 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02874560
- **Lead sponsor:** Janssen-Cilag Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-12
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-07-12
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02874560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02874560, "Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02874560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*